Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.
about
Promises and paradoxes of regulatory T cells in inflammatory bowel diseaseCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CRole of TIM-3 in ovarian cancer.High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability.Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells.Inhibitors of B7-CD28 costimulation in urologic malignancies.Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma.Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipientsPartial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.PD-1 regulates extrathymic regulatory T-cell differentiation.Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-γ producing T cells.Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantationProgrammed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.Tim-3 expression defines regulatory T cells in human tumors.Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomasImmune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis.T regulatory cells: aid or hindrance in the clearance of disease?PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid CancerImmune correlates of herpes zoster in HIV-infected children and youth.Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.The role of coinhibitory signaling pathways in transplantation and toleranceAllograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus.Regulatory T cells and systemic lupus erythematosus.FOXP3+ regulatory T cells: Current controversies and future perspectives.Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell CarcinomaEffects of lung cancer cell-associated B7-H1 on T-cell proliferation in vitro and in vivo.Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cellsExpression and function of PDCD1 at the human maternal-fetal interface.PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.Immunotherapy with regulatory T cells in transplantation.T regulatory cells in cancer: recent advances and therapeutic potential.
P2860
Q26777557-D59E29C3-30C5-4D0E-835C-0DBF4F3679CCQ27490355-6B9F1939-B3EC-42EF-945D-CBD5073F7807Q30235023-BB68BD5E-7D9A-4D6F-8421-46F48EE91B39Q30426654-F5C9B8D7-5B4E-48BA-A0ED-4FAF4388B67DQ30480631-0E9780F8-61DF-4831-AD4B-3AE5BAF1F549Q33664082-7F2232FE-2D70-4EE6-9242-9C93E550502EQ33827752-67A38E5A-387C-48DE-986D-52906D8098FBQ34033478-A15F5D86-94D7-48AA-93B9-5DF3084EDFAAQ34073891-330A2492-1E4D-4A68-8E63-6025C8E7C641Q34137984-0A292648-86E0-4DA9-AAD4-5754AA0F060CQ34193534-B0740B28-D984-4148-9CDB-80B3F9E13D3DQ34195209-09FCCF70-3F0B-4CEE-A664-B7C10F7E224CQ34427311-253D63E1-1678-4636-B066-1097090E49C2Q34454926-30C9332B-B8D1-46B5-B107-03B6662ED2A2Q34583370-51589993-5B90-4FD7-9CBE-03843FD04FC2Q34587031-21619BB4-39EA-48EB-A7BB-40BE745C0C8BQ34589567-23160AE1-F360-4E80-B4C2-4286D92081C2Q34634058-B2586911-991B-4770-894E-600FF6C4E2FCQ35070603-647EE8F1-918E-49F7-A4E8-7A580AACD467Q35110225-DB50D1A3-314F-4FE8-867B-CF0246B34B7AQ35459820-102BEFAF-7DCF-4B2E-94C0-84189FCB4AA5Q35688947-D1DB9CAF-AD6A-4A5D-BEE6-AC6FEF98D301Q35826138-35D08AD2-26A4-437B-A49B-444522D28581Q35875231-D037E9E5-DB54-4E81-86AF-D005F9B6D779Q35899277-F636C216-8C73-4F11-BD9F-91D62E5A8AC0Q35928357-053BE08A-1062-4004-ADA9-2440B01DB10CQ36068258-63CDBF19-AB88-4425-8A08-A1A543D29DA4Q36184263-CCF2AAC3-570F-4898-8F16-0D8D2A818D6AQ36570665-89783B7E-C319-4D6F-8F70-1749AB1D7AABQ36628377-44A97730-FE79-490E-8D98-2DCC7A42D1FDQ36865032-52BF45A2-EBE3-4BD8-8221-8A45893EE375Q37032948-B1A5E791-081A-4A41-9007-4678EAF39D21Q37039994-02FB4BDE-B99A-43B2-8D01-4EE26482F3C6Q37073377-46DD4395-465A-4C81-B57E-CD9B1AAE5611Q37208445-1E0F525B-CD43-4D6B-8B8E-E96826F6E34BQ37228818-A79F0131-9C77-4464-AF4C-CD473616F855Q37318142-CE42FE7F-3D40-43DE-8318-2FE794418500Q37474904-F0605216-245C-448E-B50D-CAA1E0693B60Q37773304-FA23B53E-578A-4973-8926-885AB533CA32Q37800935-737AD867-88E7-44BF-A82B-25B1D0D1DE08
P2860
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Regulated compartmentalization ...... cells from activated T cells.
@en
Regulated compartmentalization ...... cells from activated T cells.
@nl
type
label
Regulated compartmentalization ...... cells from activated T cells.
@en
Regulated compartmentalization ...... cells from activated T cells.
@nl
prefLabel
Regulated compartmentalization ...... cells from activated T cells.
@en
Regulated compartmentalization ...... cells from activated T cells.
@nl
P2093
P1476
Regulated compartmentalization ...... cells from activated T cells.
@en
P2093
Adrian E Morelli
Angus W Thomson
Daisuke Tokita
Giorgio Raimondi
William J Shufesky
P304
P356
10.4049/JIMMUNOL.176.5.2808
P407
P577
2006-03-01T00:00:00Z